Journal Information

Diabesity is a unique peer-reviewed open access interdisciplinary journal intended to publish high-quality original research on the pathogenesis of diabetes, obesity and their complications. As such the journal prioritizes studies on metabolic syndrome as a whole uncovering new knowledge on the physiology and pathophysiology of diabetes and obesity.

Diabesity focuses on clinical and experimental pharmacology and therapeutics in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. Submitted manuscripts can report any aspect of laboratory, animal, or human research, normal and pathologic pancreatic islet function and intermediary metabolism, pharmacological mechanisms of drug and hormone action, and biochemical and molecular aspects of normal and abnormal biological processes. Diabesity also welcomes manuscripts on clinical nutrition, adipogenesis and lipid metabolism, neuroscience, transgenic models, metabolic syndrome, nutrition behavior, pediatric obesity, and adipocyte cell biology.

The mission of Diabesity is to provide basic researchers and all clinicians involved in the care of people with diabetes with information on advances and the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, either in humans or animal and cellular systems.

Manuscripts investigating pharmacological and toxicological mechanisms of action and clinical studies contributing to the understanding of specific pathological problems will be given priority review and publication. Published quarterly with an open-access mandate, Discovery Diabesity offers prompt publication and presents new information on diabetes and obesity. Unsolicited review articles that are balanced, comprehensive and provide new and/or critical analysis of any aspect of drug therapy (or non-pharmacological intervention) relevant to patients with diabetes, obesity or metabolic disorders will also be considered.


DiscoverSys Inc. and eJournals

DiscoverSys is a Canadian based Pharmaceutical and Biomedical Research Consulting Company having its corporate office in Edmonton. eJournals, a not-for-profit venture and the scholarly publishing services of DiscoverSys, uses the Open Journal Systems (OJS) and creates a platform for researchers and associations to publish their quality research with an international reach. eJournals is a brainchild of dedicated professionals who have years of experience in biomedical research and publishing with an objective of helping the academic community to effectively utilize the OJS platform . Needless to say, we love open source and we are dedicated to Open Journal Systems (OJS) and Ambra (by PLOS). Our team comprises of biomedical scientists who understand the intricacies of academic publishing and creative and enthusiastic coders capable of fulfilling whatever OJS-related desire you might have, from simple solutions to top-level theme and plugin customizations. Our team of highly trained academic scientists, programmers and experienced project managers who have created hundreds of websites combine good old-fashioned service with cutting edge technology to keep our clients ahead.

DiscoverSys Specialties

Online Scholarly Publishing, Peer-Review System, Specialized in Medical Research, Emerging Open Access Publisher


Acknowledgement

Open Journal Systems (commonly known as OJS) is a journal management and publishing system that has been developed by the Public Knowledge Project through its federally funded efforts to expand and improve access to research. Public Knowledge Project is a multi-university initiative developing (free) open source software and conducting research to improve the quality and reach of scholarly publishing. This journal and DiscoverSys acknowledges the creativity and efforts by the Public Knowledge Project team on developing and continuously upgrading OJS. Please visit the Public Knowledge Project Official Website to know more and to support the initiatives of Public Knowledge Project.